Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 18, 2017
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
[ Wed, Oct 18th 2017
] - WOPRAI
Brandon Oglenski Maintained (CSX) at Buy with Increased Target to $20 on, Oct 18th, 2017
Brandon Oglenski of Barclays, Maintained "CSX Corporation" (CSX) at Buy with Increased Target from $18 to $20 on, Oct 18th, 2017.
Brandon has made no other calls on CSX in the last 4 months.
There are 4 other peers that have a rating on CSX. Out of the 4 peers that are also analyzing CSX, 1 agrees with Brandon's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Troy of "Wells Fargo" Downgraded from Buy to Hold on, Monday, October 16th, 2017
These are the ratings of the 3 analyists that currently disagree with Brandon
- Thomas Wadewitz of "UBS" Maintained at Strong Buy with Increased Target to $23 on, Monday, October 16th, 2017
- Brian Ossenbeck of "JP Morgan" Maintained at Buy with Increased Target to $21 on, Thursday, October 12th, 2017
- Ravi Shanker of "Morgan Stanley" Downgraded from Hold to Sell on, Monday, October 2nd, 2017
